FDA: Orphan Drug Workshops Scheduled For Feb. 25-26 and Aug. 3-4, 2010
As part of its continuing effort to make the agency more transparent and accessible, the FDA has scheduled a series of workshops about orphan drug designation for academics, biotechnology companies, and those unfamiliar with the process. The FDA can grant a special status, known as orphan designation, for drug products intended to treat rare diseases.